We try to cover as many aspects of autism as possible, and strive to bring you the latest autism research.

If there is something you want to know more about, contact us with your question or topic suggestion, and we will do our best to write a post about it.

Current Nº of articles:
214

Tag: Charles Grob

Dr. Grob’s clinical interests include mood and anxiety disorders, as well as the self-medication hypothesis of substance abuse as it applies to substance abuse. His research has included the first FDA approved Phase 1 study of the physiological and psychological effects of MDMA (3,4-methlyenedioxymethamphetamine), a multi-national, collaborative study of the Amazonian plant hallucinogen decoction, ayahuasca, in Brazil and a pilot investigation of the safety and efficacy of psilocybin in the treatment of anxiety in adult patients with advanced-stage cancer. His most recent research has examined the safety and efficacy of an MDMA treatment model with adult autistics with severe social anxiety.